ALTO NEUROSCIENCE INC (ANRO) Institutional Shareholders

ALTO NEUROSCIENCE INC (ANRO) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $750.88M in ANRO holdings during the latest filing period.

Alpha Wave Global, Lp is currently the largest disclosed institutional shareholder of ANRO tracked by InsiderSet, reporting ownership valued at approximately $97.85M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $112.23M, representing an estimated gain of +14.70% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 61% of the total disclosed ANRO value among the investors covered in this analysis. Major shareholders include Alpha Wave Global, Lp, Commodore Capital Lp, Blackrock, Inc., and several other long-term asset managers with concentrated positions in ALTO NEUROSCIENCE INC (ANRO).

This page ranks the largest institutional ANRO shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

113

Total Reported Value

$750.88M

Largest Holder

Alpha Wave Global, Lp

Largest Position

$97.85M

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

148

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Alpha Wave Global, Lp1.57%3,707,757$97,847,707$112,233,804+$14,386,097+14.70%
Commodore Capital Lp4.28%2,723,196$71,865,142$82,431,143+$10,566,001+14.70%
Blackrock, Inc.0.00%2,121,009$55,973,428$64,202,942+$8,229,514+14.70%
Perceptive Advisors Llc0.66%1,609,893$42,485,076$48,731,461+$6,246,385+14.70%
Adage Capital Partners Gp, L.L.C.0.06%1,600,000$42,224,000$48,432,000+$6,208,000+14.70%
Vanguard Capital Management Llc0.00%1,389,477$36,668,298$42,059,469+$5,391,171+14.70%
Spruce Street Capital Lp7.01%1,353,047$35,706,910$40,956,733+$5,249,823+14.70%
Vivo Capital, Llc2.91%1,208,858$31,901,763$36,592,132+$4,690,369+14.70%
Armistice Capital, Llc0.63%864,000$22,800,960$26,153,280+$3,352,320+14.70%
Affinity Asset Advisors, Llc1.10%850,000$22,431,500$25,729,500+$3,298,000+14.70%
Vestal Point Capital, Lp0.48%785,000$20,716,150$23,761,950+$3,045,800+14.70%
State Street Corp0.00%685,945$18,102,089$20,763,555+$2,661,466+14.70%
Geode Capital Management, Llc0.00%678,199$17,902,152$20,529,084+$2,626,932+14.67%
72 Investment Holdings, Llc35.27%667,778$17,622,661$20,213,640+$2,590,979+14.70%
Northern Trust Corp0.00%632,701$16,696,980$19,151,859+$2,454,879+14.70%
Millennium Management Llc0.01%558,320$14,734,065$16,900,346+$2,166,281+14.70%
Point72 Asset Management, L.P.0.02%502,950$13,272,851$15,224,297+$1,951,446+14.70%
Integral Health Asset Management, Llc0.54%500,000$13,195,000$15,135,000+$1,940,000+14.70%
Venrock Adviser, Llc0.40%500,000$13,195,000$15,135,000+$1,940,000+14.70%
Driehaus Capital Management Llc0.07%487,576$12,867,131$14,758,926+$1,891,795+14.70%
Parkman Healthcare Partners Llc1.16%429,035$11,322,234$12,986,889+$1,664,655+14.70%
Ikarian Capital, Llc1.76%407,338$10,749,651$12,330,121+$1,580,470+14.70%
Price T Rowe Associates Inc0.00%358,279$9,456,000$10,845,105+$1,389,105+14.69%
Orbimed Advisors Llc0.13%257,852$6,804,714$7,805,180+$1,000,466+14.70%
Schonfeld Strategic Advisors Llc0.04%257,631$6,798,881$7,798,490+$999,609+14.70%
Goldman Sachs Group Inc0.00%236,830$6,249,944$7,168,844+$918,900+14.70%
Marshall Wace, Llp0.01%225,503$5,951,025$6,825,976+$874,951+14.70%
Vanguard Fiduciary Trust Co0.00%211,257$5,575,072$6,394,749+$819,677+14.70%
Ameriprise Financial Inc0.00%190,996$5,040,385$5,781,449+$741,064+14.70%
Saturn V Capital Management Lp0.69%182,829$4,824,857$5,534,234+$709,377+14.70%
Vanguard Portfolio Management Llc0.00%181,101$4,779,255$5,481,927+$702,672+14.70%
Two Sigma Investments, Lp0.00%147,299$3,887,221$4,458,741+$571,520+14.70%
Eversept Partners, Lp0.18%128,286$3,385,468$3,883,217+$497,749+14.70%
Boothbay Fund Management, Llc0.05%106,234$2,803,515$3,215,703+$412,188+14.70%
Alkeon Capital Management Llc0.01%102,101$2,694,445$3,090,597+$396,152+14.70%
Stifel Financial Corp0.00%85,480$2,255,827$2,587,480+$331,653+14.70%
Charles Schwab Investment Management Inc0.00%80,583$2,126,585$2,439,247+$312,662+14.70%
Awm Investment Company, Inc.0.18%80,000$2,111,200$2,421,600+$310,400+14.70%
Bank Of New York Mellon Corp0.00%76,330$2,014,348$2,310,509+$296,161+14.70%
Morgan Stanley0.00%74,940$1,977,666$2,268,434+$290,768+14.70%
Renaissance Technologies LLCJim Simons0.00%71,399$1,884,220$2,161,248+$277,028+14.70%
Wellington Management Group Llp0.00%70,913$1,871,393$2,146,537+$275,144+14.70%
Advisorshares Investments Llc0.23%70,748$1,867,040$2,141,542+$274,502+14.70%
Nuveen, Llc0.00%62,342$1,645,205$1,887,092+$241,887+14.70%
Ubs Group Ag0.00%58,697$1,549,014$1,776,758+$227,744+14.70%
Acadian Asset Management Llc0.00%55,509$1,464,000$1,680,257+$216,257+14.77%
Bridgeway Capital Management, Llc0.02%50,653$1,336,733$1,533,266+$196,533+14.70%
Xtx Topco Ltd0.02%46,601$1,229,800$1,410,612+$180,812+14.70%
Td Asset Management Inc0.00%43,800$1,155,882$1,325,826+$169,944+14.70%
Dimensional Fund Advisors Lp0.00%42,561$1,123,185$1,288,321+$165,136+14.70%
Showing 50 of 113

Frequently asked questions about ANRO

  • Who owns the most ANRO stock?

    The largest holders of ANRO are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ALTO NEUROSCIENCE INC (ANRO).

  • Is ANRO widely held by superinvestors?

    Many widely followed stocks like ANRO appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ANRO is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.